News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
Mydecine Innovations Group
BetterLife Closes $2.61 Million Marketed Public Offering
BetterLife Pharma
Ketamine One Launches Immersive Virtual Reality R&D Program at MindScape Clinic
Wellbeing Digital Sciences
Psyched Wellness Hires Ad Agency, dacs Marketing to Build the Branding and Marketing Strategy for AME-1
Psyched Wellness
Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021
Field Trip Health
Algernon Pharmaceuticals Launches Pancreatic Cancer Clinical Research Program with Ifenprodil
Algernon Pharmaceuticals
Ketamine One Signs Definitive Agreement to Acquire Integrated Rehab and Performance Ltd.
Wellbeing Digital Sciences
CSE Bulletin: Delist - Field Trip Health Ltd. (FTRP, FTRP.WT)
Field Trip Health
BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors
BetterLife Pharma
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
Havn Life
Ben Lightburn | CEO, Filament Health
Filament Health
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.